Literature DB >> 12022291

Diabetic retinopathy and HLA antigens in type 2 diabetes mellitus.

A Birinci1, H Birinci, R Abidinoglu, B Durupinar, I Oge.   

Abstract

PURPOSE: Diabetic retinopathy is the most common complication of diabetes mellitus. No single predisposing factor has been identified, and genetic factors may play a role in the development of severe retinopathy. In this study, we investigated the association between diabetic retinopathy and HLA antigens in type 2 diabetes mellitus.
METHODS: This study was conducted at the retina unit of the Department of Ophthalmology of Ondokuz Mayis University between October 1999 and March 2000, and included 46 diabetics with non-proliferative retinopathy and 30 with proliferative retinopathy, with 30 nondiabetic controls. HLA class I (A, B, C) antigens were studied by Terasaki's microlymphocytotoxicity test and HLA class II (DR, DQ) typing was carried out using a polymerase chain reaction-sequence specific primer.
RESULTS: HLA-DR4 and DQ8 frequencies were higherin patients with non-proliferative retinopathy than those with proliferative retinopathy, and HLA-DR7 frequency was higher in patients with proliferative retinopathy than non-proliferative cases (p<0.05). No significant differences in HLA antigens were found between patient groups and controls.
CONCLUSIONS: The differences in HLA antigen frequencies between patients with and without proliferative retinopathy suggest a genetic contribution to diabetic retinopathy.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12022291     DOI: 10.1177/112067210201200203

Source DB:  PubMed          Journal:  Eur J Ophthalmol        ISSN: 1120-6721            Impact factor:   2.597


  4 in total

1.  Susceptible and protective human leukocyte antigen class II alleles and haplotypes in bahraini type 2 (non-insulin-dependent) diabetes mellitus patients.

Authors:  Ayesha A Motala; Marc Busson; Einas M Al-Harbi; Manal A A Khuzam; Emtiaz M D Al-Omari; Mona R Arekat; Wassim Y Almawi
Journal:  Clin Diagn Lab Immunol       Date:  2005-01

Review 2.  Possible roles of anti-type II collagen antibody and innate immunity in the development and progression of diabetic retinopathy.

Authors:  Tsunehiko Ikeda; Kimitoshi Nakamura; Teruyo Kida; Hidehiro Oku
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-08-11       Impact factor: 3.535

3.  HLA genes, islet autoantibodies and residual C-peptide at the clinical onset of type 1 diabetes mellitus and the risk of retinopathy 15 years later.

Authors:  Richard A Jensen; Elisabet Agardh; Ake Lernmark; Soffia Gudbjörnsdottir; Nicholas L Smith; David S Siscovick; Carina Törn
Journal:  PLoS One       Date:  2011-03-11       Impact factor: 3.240

Review 4.  Epidemiological issues in diabetic retinopathy.

Authors:  Peter H Scanlon; Stephen J Aldington; Irene M Stratton
Journal:  Middle East Afr J Ophthalmol       Date:  2013 Oct-Dec
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.